Amylyx Pharmaceuticals Inc (AMLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AMLX | ZTS | TAK | NBIX | UTHR |
| Company | Amylyx Pharmaceuticals Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.8300 | 169.81 | 13.40 | 137.12 | 264.35 |
| High | 1.9400 | 170.20 | 13.49 | 138.73 | 269.83 |
| Low | 1.8300 | 168.63 | 13.40 | 134.79 | 264.35 |
| Last | 1.8700 | 168.87 | 13.45 | 138.48 | 269.78 |
| Change | +0.0500 | +0.96 | +0.34 | +2.33 | +5.44 |
| % Change | +2.75% | +0.57% | +2.59% | +1.71% | +2.06% |
| Volume | 1,572,100 | 2,050,000 | 1,458,400 | 637,400 | 524,600 |
| 20-Day Average Volume | 1,932,725 | 3,830,360 | 1,514,270 | 767,575 | 579,450 |
| Previous Close | 1.8200 | 167.91 | 13.11 | 136.15 | 264.34 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.9047 | 159.72 | 13.23 | 137.96 | 249.30 |
| 20-Day Raw Stochastic | 39.53% | 87.75% | 94.44% | 55.33% | 99.86% |
| 20-Day Relative Strength | 28.24% | 54.07% | 48.76% | 50.93% | 67.47% |
| Weighted Alpha | -67.08 | -7.47 | -16.65 | +44.07 | +28.59 |
| Today's Opinion | 100% Sell | 40% Sell | 88% Sell | 88% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 100% Sell | 40% Buy | 88% Buy |
| Last Month's Opinion | 100% Sell | 88% Sell | 100% Sell | 40% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.08% since 05/07/24 | +0.25% since 05/07/24 | +1.28% since 05/07/24 | -3.29% since 05/07/24 | +1.34% since 05/07/24 |
| Low | 1.7300 on 05/09/24 | 161.00 on 05/08/24 | 12.77 on 05/09/24 | 134.79 on 05/14/24 | 260.41 on 05/09/24 |
| High | 1.9922 on 05/10/24 | 171.56 on 05/13/24 | 13.49 on 05/14/24 | 143.54 on 05/08/24 | 269.83 on 05/14/24 |
| 1-Month | |||||
| %Chg | -10.95% since 04/12/24 | +12.60% since 04/12/24 | +0.60% since 04/12/24 | +2.84% since 04/12/24 | +15.99% since 04/12/24 |
| Low | 1.7000 on 04/26/24 | 144.80 on 04/22/24 | 12.77 on 05/09/24 | 130.13 on 04/19/24 | 230.39 on 04/16/24 |
| High | 2.1400 on 04/15/24 | 172.23 on 05/07/24 | 13.49 on 05/14/24 | 145.22 on 05/01/24 | 269.83 on 05/14/24 |
| 3-Month | |||||
| %Chg | -87.59% since 02/14/24 | -8.26% since 02/14/24 | -7.50% since 02/14/24 | +5.09% since 02/14/24 | +25.81% since 02/14/24 |
| Low | 1.7000 on 04/26/24 | 144.80 on 04/22/24 | 12.77 on 05/09/24 | 129.15 on 03/01/24 | 211.61 on 02/16/24 |
| High | 19.9488 on 02/29/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 148.37 on 03/21/24 | 269.83 on 05/14/24 |
| 6-Month | |||||
| %Chg | -85.06% since 11/14/23 | -2.19% since 11/14/23 | -2.61% since 11/14/23 | +23.22% since 11/14/23 | +18.13% since 11/14/23 |
| Low | 1.7000 on 04/26/24 | 144.80 on 04/22/24 | 12.77 on 05/09/24 | 107.84 on 11/16/23 | 208.62 on 02/08/24 |
| High | 19.9488 on 02/29/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | 269.83 on 05/14/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 127,171 | 77,054,536 | 42,567,056 | 13,936,211 | 11,966,359 |
| Shares Outstanding, K | 68,006 | 456,295 | 3,164,837 | 100,637 | 44,356 |
| Annual Sales | 380,790,000 | 8,544,000,000 | 29,419,960,000 | 1,887,100,000 | 2,327,500,000 |
| Annual Net Income | 49,270,000 | 2,344,000,000 | 994,060,000 | 249,700,000 | 984,800,000 |
| Last Quarter Sales | 88,640,000 | 2,190,000,000 | 5,397,000,000 | 515,300,000 | 677,700,000 |
| Last Quarter Net Income | -118,790,000 | 599,000,000 | -91,000,000 | 43,400,000 | 306,600,000 |
| 60-Month Beta | -0.68 | 0.86 | 0.56 | 0.28 | 0.54 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.46 on 05/09/24 | 1.38 on 05/02/24 | 0.00 on 05/09/24 | 0.42 on 05/01/24 | 6.17 on 05/01/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | 03/28/18 | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 8.27 | 31.15 | 8.40 | 37.51 | 12.50 |